Management of Severe Acute Respiratory Distress Syndrome (ARDS)

Introduction

• Severe ARDS is a life-threatening condition that requires prompt and effective management to improve patient outcomes, as recommended by the American Thoracic Society and the European Society of Intensive Care Medicine 1, 2, 3

Patient Selection and NMBA Administration

• For patients with severe ARDS who require deep sedation to facilitate lung-protective ventilation or prone positioning, a neuromuscular blocking agent (NMBA) infusion for up to 48 hours is recommended over intermittent boluses, according to the Intensive Care Medicine guidelines 4
• Consider NMBA use and prone positioning in patients with severe ARDS (low oxygen levels), persistent hypoxemia despite optimized ventilation, patient-ventilator dyssynchrony despite deep sedation, inability to maintain lung-protective ventilation with deep sedation alone, or elevated plateau pressures despite optimization, as recommended by the Intensive Care Medicine guidelines 4
• The agent of choice for NMBA administration is Cisatracurium, with an initial dosing of 15 mg IV bolus followed by 37.5 mg/h infusion, as suggested by the Intensive Care Medicine guidelines 4

Ventilator Management

• The goal of ventilator management is to provide adequate oxygenation and ventilation while minimizing lung injury, as recommended by the American Thoracic Society and the European Society of Intensive Care Medicine 1, 2, 3
• Use protective lung ventilation with low tidal volume (4-8 mL/kg predicted body weight), plateau pressure <30 cmH₂O, and optimized PEEP according to severity, as recommended by the British Journal of Anaesthesia and the American Thoracic Society 5, 6, 7
• Set initial tidal volume to 6-8 mL/kg predicted body weight, with PEEP of 5 cmH2O and plateau pressure <30 cmH2O to minimize ventilator-induced lung injury 5, 6, 7
• Use FiO₂ of 0.4 (40%) after intubation and titrate to the lowest possible FiO₂ to achieve target oxygenation, as recommended by the British Journal of Anaesthesia 5
• The following table summarizes the recommended PEEP settings based on ARDS severity:

Special Considerations

• In patients with obesity, use low tidal volumes (6-8 ml/kg predicted body weight) and individual PEEP settings targeted to physiological goals, as recommended by the American Thoracic Society 10
• In patients with obstructive airway diseases, keep PEEP low (3-5 cmH₂O) to avoid worsening air trapping and dynamic hyperinflation, while in patients with restrictive lung diseases, higher PEEP (>10 cmH₂O) is recommended, as recommended by the American Thoracic Society 11
• Pregnancy creates unique respiratory challenges that affect mechanical ventilation strategies, including decreased functional residual capacity (FRC) and increased oxygen consumption, according to the American Heart Association 12

Prone Positioning and ECMO

• Consider prone positioning for patients with severe hypoxemia (PaO₂/FiO₂ <150 mmHg) for at least 12-16 hours per day, as recommended by the International Journal of Surgery, the Critical Care Society, and the American Thoracic Society 13, 6, 14, 9, 15
• Consider veno-venous ECMO in patients with severe ARDS when conventional strategies fail, especially if PaO2/FiO2 <70 mmHg for ≥3 hours or PaO2/FiO2 <100 mmHg for ≥6 hours, as recommended by the European Society of Intensive Care Medicine and the American Thoracic Society 3, 7, 9
• Consider veno-arterial ECMO when ARDS is combined with severe cardiogenic shock with low cardiac output and reduced left ventricular ejection fraction, as recommended by the European Society of Intensive Care Medicine 3

Weaning and Discontinuation

• Daily assessment for weaning readiness and use of spontaneous breathing trials in patients ready for weaning are recommended, as suggested by the European Society of Intensive Care Medicine and the Society of Critical Care Medicine 14, 16, 17, 18, 9
• A structured weaning protocol should be followed to minimize the risk of weaning failure, as recommended by the American Thoracic Society and the Society of Critical Care Medicine 9, 17, 18

Monitoring and Avoiding Harm

• Monitor adequacy of paralysis using Train-of-Four (TOF) assessment during NMBA therapy, as recommended by the Intensive Care Medicine guidelines 4
• Limit duration of NMBA therapy to 48 hours when possible, and assess for return of neuromuscular function after discontinuation, according to the Intensive Care Medicine guidelines 4
• Avoid prolonged lung recruitment maneuvers (PEEP >35 cmH₂O for >60 seconds) as they can be harmful, as recommended by the American Thoracic Society 7, 9
• Avoid excessive tidal volumes, as even small increases above recommended volumes can increase mortality, as recommended by the American Thoracic Society 6
• Avoid inadequate duration of prone positioning, as it should be maintained for at least 12 hours daily to achieve mortality benefit, as recommended by the American Thoracic Society 6
• Avoid delayed implementation of advanced therapies, and consider VV-ECMO early in severe cases that aren't responding to conventional therapy rather than as a last resort, as recommended by the American Thoracic Society 7
• Avoid overlooking driving pressure, and focus on minimizing it as it may be a better predictor of outcomes than either tidal volume or plateau pressure alone, as recommended by the American Thoracic Society 6

Outcomes and Prognosis

• The mortality rate of ARDS has decreased from 60-70% to approximately 40% in recent reports, as reported by 2
• The long-term functional outcomes for survivors are generally good, although pulmonary function abnormalities may persist if pulmonary function is impaired for more than a few days after the onset of ARDS, as reported by 2